Related Experiment Video
Updated: Mar 29, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Protracted bacterial bronchitis: The last decade and the road ahead
Anne B Chang1,2,3, John W Upham4, I Brent Masters2,3
1Child Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.
Protracted bacterial bronchitis (PBB) is a common cause of chronic cough in young children, often resolving with antibiotics. Recurrences are frequent, necessitating further investigation for conditions like bronchiectasis.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Infectious Diseases
Background:
- Chronic cough is a significant health concern in children, impacting quality of life.
- Protracted bacterial bronchitis (PBB) is a frequent cause of chronic wet cough in children under six.
- PBB is characterized by a persistent productive cough unresponsive to initial treatments, often requiring prolonged antibiotic therapy.
Purpose of the Study:
- To review the clinical presentation, diagnosis, and management of protracted bacterial bronchitis (PBB) in children.
- To explore the pathobiologic mechanisms and immune responses associated with PBB.
- To differentiate PBB from other causes of chronic wet cough, such as bronchiectasis.
Main Methods:
- Literature review of studies on childhood chronic cough and PBB.
- Analysis of clinical characteristics, diagnostic findings (including bronchoscopy and bronchoalveolar lavage), and treatment outcomes.
- Examination of immunological markers and inflammatory pathways in PBB.
Main Results:
- PBB typically presents as a chronic wet cough, often with purulent secretions and neutrophil infiltration in bronchoalveolar lavage, commonly caused by Haemophilus influenzae.
- Antibiotic treatment (e.g., amoxicillin-clavulanate) for 2-4 weeks is effective, but recurrences are common.
- Immune studies suggest activated innate immunity and increased IL-1β signaling, rather than immune deficiency, in PBB.
Conclusions:
- PBB is a distinct clinical entity treatable with antibiotics, but its high recurrence rate warrants monitoring for conditions like bronchiectasis.
- The pathogenesis of PBB involves complex inflammatory responses, with PBB and bronchiectasis potentially representing a disease spectrum.
- Further research is needed to elucidate the exact role of airway malacia and inflammatory mechanisms in PBB.
More Related Videos
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: